EI
WST icon

Ethic Inc’s West Pharmaceutical WST Stock Holding History

Ethic Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43M Buy
6,783
+1,674
+33% +$512K 0.03% 455
2026
Q1 		$1.28M Sell
5,109
-20
-0.4% -$4.98K 0.02% 584
2025
Q4 		$1.41M Sell
5,129
-1,180
-19% -$323K 0.02% 545
2025
Q3 		$1.65M Buy
6,309
+4,206
+200% +$1.02M 0.03% 495
2025
Q2 		$460K Buy
2,103
+137
+7% +$29.3K 0.01% 840
2025
Q1 		$433K Sell
1,966
-1,382
-41% -$381K 0.01% 839
2024
Q4 		$1.1M Sell
3,348
-3,751
-53% -$1.18M 0.02% 571
2024
Q3 		$2.81M Sell
7,099
-635
-8% -$194K 0.07% 313
2024
Q2 		$2.55M Buy
7,734
+635
+9% +$224K 0.06% 321
2024
Q1 		$2.81M Sell
7,099
-408
-5% -$151K 0.07% 313
2023
Q4 		$2.64M Sell
7,507
-929
-11% -$329K 0.08% 304
2023
Q3 		$3.17M Sell
8,436
-1,115
-12% -$431K 0.11% 221
2023
Q2 		$3.65M Buy
9,551
+342
+4% +$122K 0.14% 185
2023
Q1 		$3.19M Buy
9,209
+2,663
+41% +$778K 0.13% 204
2022
Q4 		$1.54M Buy
6,546
+431
+7% +$102K 0.08% 289
2022
Q3 		$1.5M Sell
6,115
-177
-3% -$53.9K 0.1% 251
2022
Q2 		$1.9M Sell
6,292
-30
-0.5% -$9.76K 0.13% 202
2022
Q1 		$2.6M Buy
6,322
+1,582
+33% +$619K 0.18% 142
2021
Q4 		$2.22M Buy
4,740
+1,087
+30% +$468K 0.17% 146
2021
Q3 		$1.55M Sell
3,653
-125
-3% -$52.7K 0.16% 166
2021
Q2 		$1.36M Buy
3,778
+638
+20% +$211K 0.16% 153
2021
Q1 		$885K Buy
3,140
+742
+31% +$212K 0.16% 173
2020
Q4 		$679K Buy
2,398
+588
+32% +$165K 0.18% 142
2020
Q3 		$498K Buy
+1,810
New +$479K 0.19% 134

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Ethic Inc's WST Position: Q2 2026 in Review

Ethic Inc increased its West Pharmaceutical (WST) stake by 33% in Q2 2026, buying an estimated $512K and bringing the position to 6,783 shares worth $2.43M. The position accounts for 0.03% of the portfolio, ranked #455.

Ethic Inc first reported a position in WST in Q3 2020 and has held it in 24 quarters since. The position peaked at $3.65M in Q2 2023. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Ethic Inc held 6,783 shares of West Pharmaceutical worth $2.43M as of Q2 2026.
  • Ethic Inc bought 1,674 West Pharmaceutical shares in Q2 2026, an estimated $512K.
  • West Pharmaceutical made up 0.03% of Ethic Inc's portfolio in Q2 2026, its #455 holding.
  • Ethic Inc first reported a position in West Pharmaceutical in Q3 2020 and has held it in 24 quarters since.
  • Ethic Inc's West Pharmaceutical position peaked at $3.65M in Q2 2023.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.